{
  "id": 4700799,
  "title": "BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines",
  "url": "https://urgent.news/2026/08/31/beone-medicines-announces-voluntary-agreement-with-u-s-government-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T19:04:20.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/beone-medicines-announces-voluntary-agreement-with-u-s-government-to-expand-access-to-innovative-cancer-medicines"
  },
  "original_language": "en",
  "account": null,
  "summary": "Agreement advances patient access and strengthens BeOne’s long-term commitment to U.S. innovation and manufacturing SAN CARLOS, Calif. — BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer",
        "url": "https://urgent.news/2026/08/31/beone-medicines-announces-new-phase-3-survival-data-reinforcing",
        "published": "2026-08-31T10:05:23.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}